![Kelly Gold](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kelly Gold
Finanzdirektor/CFO bei
CAMP4 THERAPEUTICS CORPORATION
Vermögen: 297 980 $ am 31.05.2026
Profil
Kelly Gold is currently Director & Director-Individual Fundraising at Education First, Independent Director at X4 Pharmaceuticals, Inc. starting in 2026, and Chief Financial Officer at CAMP4 Therapeutics Corp.
since 2022.
Former roles include Associate Director-Strategic Corporate Finance at Biogen, Inc. from 2014 to 2017 and Partner at Deutsche Bank AG (New York Branch) from 2009 to 2013.
Education includes an undergraduate degree from Queen's University and an MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2026 | 67’877 ( 0.14% ) | 297 980 $ | 31.05.2026 |
Aktive Positionen von Kelly Gold
| Unternehmen | Position | Beginn |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Finanzdirektor/CFO | 01.04.2022 |
| X4 PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.06.2026 |
Education First
 Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kelly Gold
| Unternehmen | Position | Ende |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2017 |
Deutsche Bank AG (New York Branch)
 Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Kelly Gold
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Deutsche Bank AG (New York Branch)
Deutsche Bank AG (New York Branch) Regional BanksFinance Provides financial and investment banking services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Education First
Education First Investment Trusts/Mutual FundsMiscellaneous Offers scholarship programs | Miscellaneous |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Wählen Sie MarketScreener 
